Charité - Universitätsmedizin Berlin

Hospital


Location: Berlin, Germany (DE) DE

ISNI: 0000000122184662

ROR: https://ror.org/001w7jn25

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Gastric neuroendocrine neoplasias: manifestations and comparative outcomes (2019) Felder S, Jann H, Arsenic R, Denecke T, Prasad , Knappe-Drzikova B, Maasberg S, et al. Journal article The German National Registry of Primary Immunodeficiencies (2012-2017) (2019) El-Helou SM, Biegner AK, Bode S, Ehl SR, Heeg M, Maccari ME, Ritterbusch H, et al. Journal article Impact of social support on psychosocial symptoms and quality of life in cancer patients: results of a multilevel model approach from a longitudinal multicenter study (2019) Sauer C, Weis J, Faller H, Junne F, Honig K, Bergelt C, Hornemann B, et al. Journal article Human nasoseptal chondrocytes maintain their differentiated phenotype on PLLA scaffolds produced by thermally induced phase separation and supplemented with bioactive glass 1393 (2019) Conoscenti G, Pavia FC, Ongaro A, Brucato V, Goegele C, Schwarz S, Boccaccini AR, et al. Journal article Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (2019) Eder T, Hess AK, Konschak R, Stromberger C, Joehrens K, Fleischer , Hummel M, et al. Journal article Fast Robust Dejitter and Interslice Discontinuity Removal in MRI Phase Acquisitions: Application to Magnetic Resonance Elastography (2019) Barnhill E, Nikolova M, Ariyurek C, Dittmann F, Braun J, Sack I Journal article Intratumoral RNA-based TLR-7/-8 and RIG-I agonist CV8102 alone and in combination with anti-PD-1 in a Phase I dose-escalation and expansion trial in patients with advanced solid tumors (2019) Eigentler T, Krauss J, Schreiber J, Weishaupt C, Terheyden P, Heinzerling L, Mohr P, et al. Conference contribution Clinical relevance of comprehensive genomic analysis in patients with advanced-stage neuroendocrine neoplasms: Results from the MASTER trial of the German Cancer Consortium (2019) Kreutzfeldt S, Apostolidis L, Oles M, Horak P, Heilig CE, Heining C, Hutter B, et al. Conference contribution Single cell identification of defined ebv epitope-specific TCR alpha beta pairs for adoptive T cell transfer against EBV infection and EBV-associated malignancies (2019) Cobo MFL, Pircher C, Dietze K, Kammertons T, Gary R, Moosmann A, Mautner J, et al. Conference contribution Results of a Multicentric Retrolective Study of Teduglutide Treatment in Benign Short Bowel Syndrome in Germany (2019) Pevny S, Wehkamp J, Zopf Y, Blumenstein I, Von Websky MW, Schiefke I, Buettner J, et al. Conference contribution